Skip to main content

Peer Review reports

From: Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

Original Submission
6 Dec 2020 Submitted Original manuscript
17 Apr 2021 Author responded Author comments - Changxing Shen
Resubmission - Version 2
17 Apr 2021 Submitted Manuscript version 2
6 May 2021 Author responded Author comments - Qing Xia
Resubmission - Version 3
6 May 2021 Submitted Manuscript version 3
26 May 2021 Author responded Author comments - Qing Xia
Resubmission - Version 4
26 May 2021 Submitted Manuscript version 4
Publishing
4 Jun 2021 Editorially accepted
22 Jun 2021 Article published 10.1186/s12885-021-08448-6

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us